Endiatx
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
25545 Whitesell St, Hayward, California,...Phone Number
(650) 838-4434Website
www.endiatx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
2
1
1
1
1
About Endiatx
Endiatx is developing PillBot, a remote-controlled, disposable endoscopy pill designed for real-time, non-invasive stomach diagnostics. This innovative device aims to provide faster, anesthesia-free results in a single appointment, significantly reducing the need for traditional invasive procedures. Targeting over 75 million patients annually who require endoscopy, PillBot offers a low-cost alternative that eliminates multiple clinic visits and long wait times. Currently, PillBot is an investigational medical device under evaluation and not yet available for commercial use.Explore more
Endiatx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Endiatx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Endiatx has new funding data
Endiatx, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Endiatx had a recent Job posting/layoffs
Product Launch: Get notified when Endiatx launches new products
Congratulate Masked Content for being promoted to Masked Content at Endiatx
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Endiatx recently announced quarterly report
Check out if Endiatx is spiking on competitors!
Check if Endiatx has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Endiatx
Compare insights from companies similar to Endiatx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Endiatx is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Endiatx is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Endiatx.
Endiatx Tech Stack
A closer look at the technologies used by Endiatx
Most Recent Scoops
Hiring Plans
Endiatx has more open roles in Engineering & Technical than it has had at any time in the past 12 months.
Hiring Plans
Open Position
New Hire
Executive Move
Endiatx has announced that Arman Nadershahi has joined the organization as Chief Executive Officer.
Executive Moves, New Hire
New Hire
Executive Move
Endiatx News & Media
Swallow this robot: Ediatx’s tiny pill examines your body with cameras, sensors
FEATURE: Endiatx's swallowable robotic pill hits clinical trials, company preps for FDA review and commercial launchMayo Clinic picks up stake in startup making pill-sized robot - Becker's Hospital Review
Rochester, Minn.-based Mayo Clinic has obtained a stake in Endiatx, a startup making a pill-sized robot to diagnose digestive conditions.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Endiatx
Sign Up For FreeTo access detailed company insights
Endiatx is developing PillBot, a remote-controlled, disposable endoscopy pill designed for real-time, non-invasive stomach diagnostics. This innovative device aims to provide faster, anesthesia-free results in a single appointment, significantly reducing the need for traditional invasive procedures. Targeting over 75 million patients annually who r... Read More
